VNUE (VNUE) S-1 16 Jun 23 IPO registration Financial data

Cover

Cover	3 Months Ended
	Mar. 31, 2023
Cover [Abstract]
Document Type	S-1
Amendment Flag	false
Entity Registrant Name	VNUE, INC.
Entity Central Index Key	0001376804
Entity Tax Identification Number	98-0543851
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	104 West 29th Street,
Entity Address, Address Line Two	11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	833
Local Phone Number	937-5493
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false

CONSOLIDATED BALANCE SHEETS (Un

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 54,191	$ 82,807
Prepaid expenses	261,100	130,000
Total current assets	315,291	212,807
Fixed assets, net		9,134
Total assets	315,291	221,941
Current liabilities:
Accounts payable and accrued expenses	2,886,567	2,817,104
Shares to be issued	975,174	975,174
Accrued payroll-officers	198,550	212,250
Dividends payable	276,083	210,486
Notes payable	1,159,262	1,134,262
Deferred revenue	872,990	862,597
Convertible notes payable, net	470,714	470,714
Total current liabilities	6,839,340	6,682,587
Total liabilities	6,839,340	6,682,587
Commitments and Contingencies
Stockholders’ Deficit
Common stock, par value $0.0001, 4,000,000,000 shares authorized; 1,783,508,869 and 1,676,014,753 shares issued and outstanding, as of March 31, 2023, and December 31, 2022, respectively	178,350	167,601
Additional paid-in capital	30,544,579	30,179,731
Accumulated deficit	(37,247,403)	(36,808,403)
Total stockholders’ deficit	(6,524,049)	(6,460,646)
Total Liabilities and Stockholders’ Deficit	315,291	221,941
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value	425	425
Series B Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value
Series C Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value

CONSOLIDATED BALANCE SHEETS (_2

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Common Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Common Stock, Shares Authorized		4,000,000,000	2,000,000,000
Common Stock, Shares, Outstanding	1,783,508,869	1,676,014,753	1,411,799,497
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Outstanding	4,250,579	4,250,579	4,250,579
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	2,500	2,500	2,500
Preferred Stock, Shares Outstanding	2,422	2,305	0
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized		100,000	100,000
Preferred Stock, Shares Outstanding	3,000	0

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Revenues - related party	$ 3,875	$ 5,049
Revenue, net	84,870	36,621
Total revenue	88,745	41,670
Direct costs of revenue	48,202	40,513
Gross profit	40,543	1,157
Operating expenses:
General and administrative expense	104,817	63,202
Payroll expenses	127,101	121,551
Professional fees	120,775	351,953
Amortization of intangible assets		108,333
Total operating expenses	352,693	645,039
Operating loss	(312,150)	(643,882)
Other income (expense), net
Financing costs	(61,254)	(549,224)
Other income (expense), net	(61,254)	(549,224)
Net loss	(373,404)	(1,193,106)
Preferred B Stock dividends	(65,596)
Net loss available to common shareholders	$ (439,000)	$ (1,193,106)
Net loss per common share - basic and diluted	$ 0	$ 0
Weighted average common shares outstanding:
Basic and diluted	1,714,131,603	1,415,312,830

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Preferred A Shares [Member]	Preferred B Shares [Member]	Preferred C Share [Member]	Common Stocks [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - December 31, 2022 at Dec. 31, 2020	$ 413				$ 8,386,593	$ (16,755,676)	$ (8,247,521)
Beginning balance, shares at Dec. 31, 2020	4,126,776
Shares issued upon conversion of convertible notes payable	$ 12				1,273,991		1,281,523
Shares issued upon conversion of convertible notes payable, shares	123,803
Net loss						2,920,382	2,920,382
Ending balance, value at Dec. 31, 2021	$ 425			$ 141,177	10,900,652	(13,835,294)	(2,793,040)
Ending balance, shares at Dec. 31, 2021	4,250,579			1,411,799,497
Issuance of Preferred B Shares for cash					1,500,000		1,500,000
Issuance of Preferred B Shares for cash, shares		1,500
Financing fee paid in Preferred B shares					42,000		42,000
Financing fee paid in Preferred B shares, shares		35
Beneficial conversion feature of Pref B shares convertible notes					300,000		300,000
Shares issued for services				$ 600	56,200		56,800
Shares issued for services, shares				6,000,000
Shares issued upon conversion of convertible notes payable				$ 4,148	414,770		418,918
Shares issued upon conversion of convertible notes payable, shares				41,476,963
Net loss						(1,193,106)	(1,193,106)
Ending balance, value at Mar. 31, 2022	$ 425			$ 145,925	13,213,622	(15,028,400)	(1,668,428)
Ending balance, shares at Mar. 31, 2022	4,250,579	1,535		1,459,276,460
Balance - December 31, 2022 at Dec. 31, 2021	$ 425			$ 141,177	10,900,652	(13,835,294)	(2,793,040)
Beginning balance, shares at Dec. 31, 2021	4,250,579			1,411,799,497
Issuance of Preferred B Shares for cash					1,964,600		1,964,600
Issuance of Preferred B Shares for cash, shares		1,980
Financing fee paid in Preferred B shares					68,400		68,400
Financing fee paid in Preferred B shares, shares		59
Series B dividends						(210,486)	(210,486)
Shares issued from the Company’s equity line for cash					506,743		526,269
Beneficial conversion feature of Pref B shares convertible notes					434,200		434,200
Shares issued for services					56,200		56,800
Net loss						(22,762,622)	(22,762,622)
Ending balance, value at Dec. 31, 2022	$ 425			$ 167,601	30,179,731	(36,808,403)	(6,460,646)
Ending balance, shares at Dec. 31, 2022	4,250,579	2,305		1,676,014,753
Issuance of Preferred B Shares for cash					111,000		111,000
Issuance of Preferred B Shares for cash, shares		111
Financing fee paid in Preferred B shares					6,000		6,000
Financing fee paid in Preferred B shares, shares		6
Series B dividends						(65,596)	(65,596)
Shares issued from the Company’s equity line for cash				$ 10,749	247,848		258,597
Net loss						(373,404)	(373,404)
Shares issued for the Companys equity line for cash, shares				107,494,116
Ending balance, value at Mar. 31, 2023	$ 425			$ 178,350	$ 30,544,579	$ (37,247,403)	$ (6,524,049)
Ending balance, shares at Mar. 31, 2023	4,250,579	2,422		1,783,508,869

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Cash Flows From Operating Activities:
Net loss	$ (373,404)	$ (1,193,106)	$ (22,762,622)	$ 2,920,382
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Depreciation	9,134	1,880	28,688
Amortization of intangible assets		108,333	758,333
Change in the fair value of derivatives		300,000		(3,156,582)
Beneficial conversion feature of Preferred B stock	11,000		434,200
Shares issued for financing costs	6,000	42,000
Shares issued for services		56,800	56,800
Changes in operating assets and liabilities
Prepaid expenses	(131,100)	364,336	334,336	(364,337)
Accounts payable and accrued interest	69,464	67,820	189,262	(1,045,767)
Deferred revenue	10,393	5,198	10,469
Accrued payroll officers	(13,700)	(2,000)	(21,500)	24,000
Net cash used in operating activities	(412,213)	(248,739)	(1,276,439)	(1,430,312)
Cash Flows From Investing Activities:
Acquisition of a business net of cash received		(977,761)	(977,761)
Net cash used in investing activities		(977,761)	(978,701)
Cash Flows From Financing Activities:
Proceeds from the Company’s equity line from the sale of common stock	258,597
Payments on promissory notes	25,000	(253,000)	(261,280)	(22,000)
Proceeds from the sale of Series B Preferred Stock	100,000	1,500,000
Proceeds from the issuance of convertible notes		3,000	3,000	334,000
Net cash provided by investing activities	383,597	1,250,000	2,300,989	1,462,812
Net Increase (Decrease) In Cash	(28,616)	23,500	45,848	32,501
Cash At The Beginning Of The Period	82,807	36,958	36,958
Cash At The End Of The Period	54,191	60,458	82,807	36,958
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes

CONSOLIDATED BALANCE SHEET

CONSOLIDATED BALANCE SHEET - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 54,191	$ 82,807	$ 36,958
Prepaid expenses	261,100	130,000	464,336
Total current assets	315,291	212,807	501,294
Fixed assets, net		9,134	0
Total assets		221,942	501,294
Current liabilities:
Accounts payable and accrued expenses		2,817,102	923,781
Shares to be issued	975,174	975,174	247,707
Accrued payroll-officers	198,550	212,250	233,750
Advances from officer			10,000
Dividends payable	276,083	210,486
Notes payable	1,159,262	1,134,262	869,157
Deferred revenue	872,990	862,597	74,225
Convertible notes payable, net	470,714	470,714	635,714
Purchase liability			300,000
Total current liabilities		6,682,586	3,294,334
Total liabilities		6,682,586	3,294,334
Commitments and Contingencies
Stockholders’ Deficit
Common stock, par value $0.0001, 2,000,000,000 shares authorized; and 1,676,014,753 and 1,411,799,497 shares issued and outstanding, as of December 31, 2022, and December 31, 2021, respectively	178,350	167,601	141,177
Additional paid-in capital	30,544,579	30,179,731	10,900,652
Accumulated deficit	(37,247,403)	(36,808,403)	(13,835,294)
Total stockholders’ deficit	(6,524,049)	(6,460,646)	(2,793,040)
Total Liabilities and Stockholders’ Deficit		221,942	501,294
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value	425	425	425
Series B Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value
Series C Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value

CONSOLIDATED BALANCE SHEET (Par

CONSOLIDATED BALANCE SHEET (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Common Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Common Stock, Shares Authorized		4,000,000,000	2,000,000,000
Common Stock, Shares, Outstanding	1,783,508,869	1,676,014,753	1,411,799,497
Series A Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Outstanding	4,250,579	4,250,579	4,250,579
Series B Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	2,500	2,500	2,500
Preferred Stock, Shares Outstanding	2,422	2,305	0
Series C Preferred Stock [Member]
Preferred Stock, Par or Stated Value Per Share		$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized		100,000	100,000
Preferred Stock, Shares Outstanding	3,000	0

CONSOLIDATED STATEMENT OF OPERA

CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues - related party	$ 11,818	$ 100,476
Revenue, net	347,329
Total revenue	359,147	100,476
Direct costs of revenue	325,878	153,181
Gross profit	33,269	(52,705)
Operating expenses:
Issuance of Preferred C voting stock -related party	15,300,000
General and administrative expense	500,633	149,425
Payroll expenses	302,277	303,261
Professional fees	727,052	479,448
Amortization of intangible assets	758,333
Impairment of goodwill and intangible assets, net of earnout reversal	4,261,683
Total operating expenses	21,849,979	932,134
Operating loss	(21,816,710)	(984,839)
Other income (expense), net
Change in fair value of derivative liability		3,156,582
Other income		1,172,789
Loss on the extinguishment of debt	(133,911)	(80,227)
Financing costs	(812,001)	(343,923)
Other income (expense), net	(945,912)	3,905,221
Net loss	(22,762,622)	2,920,382
Preferred B Stock dividends	(210,486)
Net loss available to common shareholders	$ (22,973,109)	$ 2,920,382
Net loss per common share - basic and diluted	$ (0.02)	$ 0
Weighted average common shares outstanding:
Basic	1,495,043,842	1,300,621,328
Diluted	1,495,043,842	1,311,935,180

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Preferred A Shares [Member]	Preferred B Shares [Member]	Preferred C Shares [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - December 31, 2022 at Dec. 31, 2020	$ 413			$ 121,149	$ 8,386,593	$ (16,755,676)	$ (8,247,521)
Beginning balance, shares at Dec. 31, 2020	4,126,776			1,211,495,162
Beneficial conversion feature of convertible notes					111,765		111,765
Net loss						2,920,382	2,920,382
Shares issued upon conversion of convertible notes payable	$ 12			$ 7,520	1,273,991		1,281,523
Shares issued upon conversion of convertible notes payable, shares	123,803			75,195,174
Private placement of common shares				$ 12,509	1,128,303		1,140,812
Private placement of common shares, shares				125,089,161
Ending balance, value at Dec. 31, 2021	$ 425			$ 141,177	10,900,652	(13,835,294)	(2,793,040)
Ending balance, shares at Dec. 31, 2021	4,250,579			1,411,779,497
Net loss						(1,193,106)	(1,193,106)
Shares issued upon conversion of convertible notes payable					414,770		418,918
Issuance of Preferred B Shares for cash					1,500,000		1,500,000
Issuance of Preferred B Shares for cash, shares		1,500
Financing fee paid in Preferred B shares					42,000		42,000
Financing fee paid in Preferred B shares, Shares		35
Beneficial conversion feature of Preferred B shares					300,000		300,000
Shares issued for services					56,200		56,800
Ending balance, value at Mar. 31, 2022	$ 425				13,213,622	(15,028,400)	(1,668,428)
Ending balance, shares at Mar. 31, 2022	4,250,579	1,535
Balance - December 31, 2022 at Dec. 31, 2021	$ 425			$ 141,177	10,900,652	(13,835,294)	(2,793,040)
Beginning balance, shares at Dec. 31, 2021	4,250,579			1,411,779,497
Net loss						(22,762,622)	(22,762,622)
Issuance of Preferred B Shares for cash					1,964,600		1,964,600
Issuance of Preferred B Shares for cash, shares		1,980
Conversion of debt to Preferred B Shares					319,200		319,200
Conversion of debt to Preferred B shares, Shares		266
Financing fee paid in Preferred B shares					68,400		68,400
Financing fee paid in Preferred B shares, Shares		59
Issuance of Preferred C voting shares					15,300,000		15,300,000
Issuance of Preferred C voting shares, shares			3,000
Series B dividends						(210,486)	(210,486)
Beneficial conversion feature of Preferred B shares					434,200		434,200
Shares issued for the Company’s equity line				$ 19,526	506,743		526,269
Shares issued for the Companys equity line, shares				195,261,678
Shares issued for services				$ 600	56,200		56,800
Shares issued for services, Shares				6,000,000
Acquisition shares issued for Stage It purchase				$ 6,297	629,736		636,033
Acquisition shares issued for Stage It purchase, Shares				62,973,578
Ending balance, value at Dec. 31, 2022	$ 425			$ 167,601	30,179,731	(36,808,403)	(6,460,646)
Ending balance, shares at Dec. 31, 2022	4,250,579	2,305	3,000	1,676,014,753
Net loss						(373,404)	(373,404)
Issuance of Preferred B Shares for cash					111,000		111,000
Issuance of Preferred B Shares for cash, shares		111
Financing fee paid in Preferred B shares					6,000		6,000
Financing fee paid in Preferred B shares, Shares		6
Series B dividends						(65,596)	(65,596)
Shares issued for the Company’s equity line					247,848		258,597
Ending balance, value at Mar. 31, 2023	$ 425				$ 30,544,579	$ (37,247,403)	$ (6,524,049)
Ending balance, shares at Mar. 31, 2023	4,250,579	2,422

CONSOLIDATED STATEMENT OF CASH

CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Cash Flows From Operating Activities:
Net income (loss)	$ (373,404)	$ (1,193,106)	$ (22,762,622)	$ 2,920,382
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Depreciation	9,134	1,880	28,688
Amortization of intangible assets		108,333	758,333
Change in the fair value of derivatives		300,000		(3,156,582)
Loss on the extinguishment of debt			133,911	80,227
Beneficial conversion feature of Preferred B stock	11,000		434,200
Issuance of Preferred C voting stock -related party			15,300,000
Impairment of goodwill and intangible assets, net of earnout reversal	4,261,683		4,261,683
Shares issued for services		56,800	56,800
Amortization of debt discount				111,765
Changes in operating assets and liabilities, net of acquired amounts
Prepaid expenses	(131,100)	364,336	334,336	(364,337)
Accounts payable and accrued interest	69,464	67,820	189,262	(1,045,767)
Deferred revenue	10,393	5,198	10,469
Accrued payroll officers	(13,700)	(2,000)	(21,500)	24,000
Net cash used in operating activities	(412,213)	(248,739)	(1,276,439)	(1,430,312)
Cash Flows From Investing Activities:
Purchase of fixed assets			(940)
Acquisition of a business net of cash received		(977,761)	(977,761)
Net cash used in investing activities		(977,761)	(978,701)
Cash Flows From Financing Activities:
Repayment of officer advance			(10,000)	10,000
Payments on promissory notes	25,000	(253,000)	(261,280)	(22,000)
Shares issued for financing costs			68,400
Proceeds from the private placement of common shares			526,269	1,140,812
Proceeds from the sale of Series B Preferred Stock			1,964,600
Proceeds from the issuance of convertible notes		3,000	3,000	334,000
Net cash provided by investing activities	383,597	1,250,000	2,300,989	1,462,812
Net Increase (Decrease) In Cash	(28,616)	23,500	45,848	32,501
Cash At The Beginning Of The Period	82,807	36,959	36,959	4,458
Cash At The End Of The Period			82,807	36,959
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Supplemental disclosure of non-cash information:
Stage It acquisition			636,033
Preferred B shares issued upon the conversion of debt and accrued interest			$ 319,200

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE”, “TGRI”, or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006. On May 29, 2015, VNUE, Inc. entered into a merger agreement with VNUE Washington, Inc. Pursuant to the terms of the Merger Agreement, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 shares of TGRI common stock. As a result of the Merger, VNUE Washington became a wholly-owned subsidiary of the Company, and the transaction was accounted for as a reverse merger with VNUE Washington deemed the acquiring company for accounting purposes, and the Company deemed the legal acquirer. The Company is developing technology-driven solutions for Artists, Venues, and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights. On February 13, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). On February 13, 2022, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company contracted to acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). At the same time, Stage It and several of the shareholders of Stage It entered into a voting agreement concerning the Merger. Pursuant to the Merger Agreement, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) were converted into the right to receive the applicable portion of the Merger Consideration. $ 1,085,450 of the Merger Consideration was paid in cash and satisfaction of certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion was paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, was held back for the purposes of satisfying certain contingent obligations of Stage It. The Merger Agreement provides for the issuance of earnout shares which the company estimates will not be achieved. On February 14 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company issued the initial 135,000,000 shares, paid certain amounts to Stage It vendors and will potentially pay additional amounts as detailed under Merger Consideration in the Merger Agreement.	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION History and Organization VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE”, “TGRI”, or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006. On May 29, 2015, VNUE, Inc. entered into a merger agreement with VNUE Washington, Inc. Pursuant to the terms of the Merger Agreement, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 shares of TGRI common stock. As a result of the Merger, VNUE Washington became a wholly-owned subsidiary of the Company, and the transaction was accounted for as a reverse merger with VNUE Washington deemed the acquiring company for accounting purposes, and the Company deemed the legal acquirer. The Company is developing technology-driven solutions for Artists, Venues, and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights. On February 13, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). On February 13, 2022, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company contracted to acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). At the same time, Stage It and several of the shareholders of Stage It entered into a voting agreement concerning the Merger. Pursuant to the Merger Agreement, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) were converted into the right to receive the applicable portion of the Merger Consideration. $ 1,085,450 of the Merger Consideration was paid in cash and satisfaction of certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion was paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, was held back for the purposes of satisfying certain contingent obligations of Stage It. The Merger Agreement provides for the issuance of earnout shares which the company estimates will not be achieved. On February 14 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company issued the initial 135,000,000 shares, paid certain amounts to Stage It vendors and will potentially pay additional amounts as detailed under Merger Consideration in the Merger Agreement.

GOING CONCERN

GOING CONCERN	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements as of March 31, 2023, the Company had $ 54,191 in cash on hand, had negative working capital of $ 6,524,049 and had an accumulated deficit of $ 37,247,403 . Additionally, for the three months ended March 31, 2023, the Company used $ 412,213 in cash from operating activities. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The Company does not have any commitments for additional capital. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s March 31, 2023, consolidated financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern. The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. Historically, the Company has been able to fund its operations from the proceeds of notes payable and convertible notes. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements as of December 31, 2022, the Company had $ 82,807 6,469,779 36,808,403 1,276,439 The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. Historically, the Company has been able to fund its operations from the proceeds of notes payable and convertible notes. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

SIGNIFICANT AND CRITICAL ACCOUN

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	NOTE 3 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Consolidation The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed, the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer; however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. The Company also recognizes revenue from the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed, which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. As of March 31, 2023 and December 31, 2022, deferred revenue amounted to $ 872,990 and $ 862,597 , respectively. As of March 31, 2023, deferred revenue was comprised of two amounts, $74,225 at VNUE related to the Matchbox Twenty Tour with Rob Thomas that was cancelled due to Covid-19, and $ 798,765 in unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive approximately 80%, and the Company will record 20% of the value of these notes as revenue. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Stock Purchase Warrants The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments, such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. There were no derivative liabilities outstanding as of March 31, 2023 and December 31, 2022. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on March 31, 2023, because their impact would have been anti-dilutive. Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows: Schedule of property plant equipment estimated useful lives Computers, software, and office equipment 3 years Furniture and fixtures 7 years As of March 31, 2023, the Company’s property, which consisted solely of computers at its Stage It subsidiary, was fully depreciated. Depreciation expense for the three months ended March 31, 2023, and 2022, amounted to $ 9,134 and $ 1,880 , respectively. Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years. Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. As of December 31, 2022, the Company determined that its goodwill and intangibles were fully impaired, and as a result, recorded an impairment of goodwill and intangible assets amounting to $ 4,261,683 in its Statements Operations for the year ended December 31, 2022. Recently Issued Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material effect on the Company’s financial statements and financial statement disclosures.	NOTE 3 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES Basis of Consolidation The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. The Company also recognizes revenue on the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. As of December 31, 2022 and December 31, 2021 deferred revenue amounted to $ 862,597 74,225 , respectively. As of December 31, 2022, deferred revenue was comprised of two amounts, $74,225 at VNUE related to the Matchbox Twenty Tour with Rob Thomas that was cancelled due to Covid-19, and $ 788,372 in unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes will be redeemed, on average the performing artists will receive 80%, and the Company will record 20% of the value of these notes as revenue. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for the determination of goodwill and intangible assets, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates. Stock Purchase Warrants The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity. Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. There were no derivative liabilities outstanding as of December 31, 2022 and December 31, 2021. Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2022, because their impact would have been anti-dilutive. Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows: Schedule of Property Plant Equipment Estimated Useful Lives Computers, software, and office equipment 3 years Furniture and fixtures 7 years As of December 31, 2022 and 2021, the Company’s property, which consisted solely of computers at its Stage It subsidiary, amounted to $ 9,134 , net of accumulated depreciation and -$- 0 - respectively. Depreciation expense for the year ended December 31, 2022, and 2021, amounted to $ 28,688 and $- 0 - respectively. Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years. Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. As of December 31, 2022 the Company determined that its goodwill and intangibles were fully impaired, and as a result recorded an impairment of goodwill and intangible assets amounting to $ 4,261,683 in its Statements Operations for the year ended December 31, 2022. Recently Issued Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material effect on the Company’s financial statements and financial statement disclosures.

PREPAID EXPENSE

PREPAID EXPENSE	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSE	NOTE 4 – PREPAID EXPENSE As of March 31, 2023 and December 31, 2022, the balances in prepaid expenses was $ 261,100 and $ 130,000 . Schedule of prepaid expense March 31, December 31, Matchbox Twenty agreement $ 100,000 $ 100,000 Deposit with joint venture partner 161,100 30,000 Total prepaid expenses $ 261,100 $ 130,000 $ 100,000 of the prepaid expense in both periods relates to a January 9, 2020 agreement entered into by the Company with recording and performance artist, Matchbox Twenty “MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020. This tour which has been delayed due to Covid-19 is expected to commence in May 2023.	NOTE 4 – PREPAID EXPENSE As of December 31, 2022 and December 31, 2021, the balances in prepaid expenses was $ 130,000 and $ 464,336 . Schedule Of Prepaid Expense December 31, December 31, Matchbox Twenty agreement $ 100,000 $ 100,000 Deposit with joint venture partner 30,000 - Pre-acquisition expenses paid at Stage It - 364,336 Total prepaid expenses $ 130,000 $ 464,336 $ 100,000 of the prepaid expense in both periods relates to a January 9, 2020 agreement entered into by the Company with recording and performance artist, Matchbox Twenty “MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020. This tour which has been delayed due to Covid-19 is expected to commence in May, 2023.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS DiscLive Network On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive, for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license. In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer. Revenues of $ 3,875 and $ 5,049 for the periods ended March 31, 2023, and 2022, respectively, were recorded using the assets licensed under this agreement. For the periods ended March 31, 2023, and 2022 the fees would have amounted to $ 194 and $ 252 , respectively. The Company’s Chief Executive Officer agreed to waive the right to receive these license fees for both years and has never taken any fees pursuant to this agreement. Advances from Officers/Stockholders From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2021, the Company’s Chief Executive Officer advanced $ 10,000 to the Company on an interest-free basis. That amount was repaid in the fourth quarter of 2022.	NOTE 5 – RELATED PARTY TRANSACTIONS DiscLive Network On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive, for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license. In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer. Revenues of $ 11,818 and $ 100,476 for the periods ended December 31, 2022, and 2021, respectively, were recorded using the assets licensed under this agreement. For the periods ended December 31, 2022, and 2021 the fees would have amounted to $ 591 and $ 5,024 respectively. The Company’s Chief Executive Officer agreed to waive the right to receive these license fees for both years and has never taken any fees pursuant to this agreement. Advances from Officers/Stockholders From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2021, the Company’s Chief Executive Officer advanced $ 10,000 to the Company on an interest-free basis. That amount was repaid in the fourth quarter of 2022.

BUSINESS ACQUISITION

BUSINESS ACQUISITION	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
BUSINESS ACQUISITION	NOTE 6 – BUSINESS ACQUISITION On February 13, 2022, VNUE, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly owned subsidiary of the Company (the “Merger”). Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back to satisfy certain contingent obligations of Stage It. The Merger Agreement also allows for the issuance of earn-out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months. On February 13, 2022, the Company, Stage It and the shareholders of Stage It entered into a voting agreement concerning the Merger. On February 14, 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company will issue the initial 135,000,000 shares and pay certain amounts as detailed under Merger Consideration in the Merger Agreement. The price to be paid in cash and stock for the Earnout Shares and Holdback Shares are set forth in the Merger Agreement. The Merger Agreement has been included to provide investors with information regarding its terms. The representations, warranties, and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Merger Agreement, and may not have been intended to be statements of fact, but rather as a method of allocating risk and governing the contractual rights and relationships among the parties to the Merger Agreement. In addition, such representations, warranties, and covenants may have been qualified by certain disclosures not reflected in the text of the Merger Agreement and may apply standards of materiality and other qualifications and limitations in a way that is different from what may be viewed as material by the Company’s shareholders. None of the Company’s shareholders or any other third party should rely on the representations, warranties, and covenants, or any descriptions thereof, as characterizations of the actual state of facts or conditions of the Company, the Company, Merger Sub, or any of their respective subsidiaries or affiliates For the acquisition of Stage It, the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed: Consideration paid Schedule of fair value of consideration Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share $ 418,917 Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share 944,583 Net liabilities assumed 2,871,066 Cash paid 1,085,450 Fair value of total consideration paid $ 5,320,016 Net assets acquired and liabilities assumed Schedule of net asset acquired and liabilities assumed Cash and cash equivalents $ 107,689 Computer equipment 36,882 Total assets 144,571 Accounts payable and accrued liabilities 1,711,349 Notes payable 526,385 Deferred revenue 777,903 Total liabilities $ 3,015,637 Net liabilities assumed $ 2,871,066 The Company has allocated the fair value of the total consideration paid of $ 10,400,000 to goodwill and $ 2,600,000 to intangible assets with a life of three years. The value of goodwill represents Stage It’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill on March 31, 2022, and did not complete a valuation study with an independent third party. During the year ended December 31, 2022, the Company recorded $ 758,333 in amortization expense. On December 31, 2022, the Company, based on its internal analysis, estimated that its Stage It subsidiary would not achieve its Earnout and that all of the goodwill and intangible assets relating to the acquisition of Stage It was fully impaired. As a result, the Company recorded an impairment of goodwill and intangible assets charge net of the earnout reversal of $ 4,262,683 on its Statements of Operations for the year ended December 31, 2022. The amount of $ 4,262,683 was calculated as follows: Schedule of net impairment Goodwill impairment $ 10,400,000 Intangible assets impairment 1,542,847 Reversal of Earnout liability (7,679,984 ) Net impairment $ 4,262,863	NOTE 6 – BUSINESS ACQUISITION On February 13, 2022, VNUE, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly owned subsidiary of the Company (the “Merger”). Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back to satisfy certain contingent obligations of Stage It. The Merger Agreement also allows for the issuance of earn-out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months. On February 13, 2022, the Company, Stage It and the shareholders of Stage It entered into a voting agreement concerning the Merger. On February 14, 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company will issue the initial 135,000,000 shares and pay certain amounts as detailed under Merger Consideration in the Merger Agreement. The price to be paid in cash and stock for the Earnout Shares and Holdback Shares are set forth in the Merger Agreement. The Merger Agreement has been included to provide investors with information regarding its terms. The representations, warranties, and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Merger Agreement, and may not have been intended to be statements of fact, but rather as a method of allocating risk and governing the contractual rights and relationships among the parties to the Merger Agreement. In addition, such representations, warranties, and covenants may have been qualified by certain disclosures not reflected in the text of the Merger Agreement and may apply standards of materiality and other qualifications and limitations in a way that is different from what may be viewed as material by the Company’s shareholders. None of the Company’s shareholders or any other third party should rely on the representations, warranties, and covenants, or any descriptions thereof, as characterizations of the actual state of facts or conditions of the Company, the Company, Merger Sub, or any of their respective subsidiaries or affiliates For the acquisition of Stage It the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed: Consideration paid Schedule of fair value of consideration Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share $ 418,917 Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share 944,583 Net liabilities assumed 2,871,066 Cash paid 1,085,450 Fair value of total consideration paid $ 5,320,016 Net assets acquired and liabilities assumed Schedule of net asset acquired and liabilities assumed Cash and cash equivalents $ 107,689 Computer equipment 36,882 Total assets 144,571 Accounts payable and accrued liabilities 1,711,349 Notes payable 526,385 Deferred revenue 777,903 Total liabilities $ 3,015,637 Net liabilities assumed $ 2,871,066 The Company has allocated the fair value of the total consideration paid of $ 10,400,000 to goodwill and $ 2,600,000 to intangible assets with a life of three years. The value of goodwill represents Stage It’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill on March 31, 2022 and did not complete a valuation study with an independent third party During the year ended December 31, 2022, the Company recorded $ 758,333 in amortization expense. On December 31, 2022 the Company, based on its internal analysis estimated that its Stage It subsidiary would not achieve its Earnout and that all of the goodwill and intangible assets relating to the acquisition of Stage It was fully impaired. As a result the Company recorded an impairment of goodwill and intangible assets charge net of the earnout reversal of $ 4,262,683 The amount of $4,262,683 was calculated as follows: Schedule of Net impairment Goodwill impairment $ 10,400,000 Intangible assets impairment 1,542,847 Reversal of Earnout liability (7,679,984 ) Net impairment $ 4,262,863

DEFERRED REVENUE

DEFERRED REVENUE	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Revenue Recognition and Deferred Revenue [Abstract]
DEFERRED REVENUE	NOTE 7 – DEFERRED REVENUE As of March 31, 2023 and December 31, 2022, deferred revenue amounted to $ 872,990 and $ 862,597 , respectively. As of March 31, 2023, deferred revenue was comprised of two amounts, $74,225 at VNUE related to the Matchbox Twenty Tour with Rob Thomas that was cancelled due to Covid-19, and $ 798,765 in unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive 80%, and the Company will record 20% of the value of these notes as revenue.	NOTE 7 – DEFERRED REVENUE As of December 31, 2022 and December 31, 2021 deferred revenue amounted to $ 862,597 74,225 788,372

ACCOUNTS PAYABLE AND ACCRUED LI

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 8 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on March 31, 2023, and December 31, 2022: Schedule of accrued liabilities March 31, 2023 December 31, 2022 Accounts payable and accrued expense $ 2,435,129 $ 2,389,231 Accrued interest 306,178 282,612 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 2,886,566 $ 2,817,102	NOTE 8 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability. The following table sets forth the components of the Company’s accrued liabilities on December 31, 2022, and December 31, 2021: Schedule of accrued liabilities December 31, 2022 December 31, 2021 Accounts payable and accrued expense $ 2,389,231 $ 588,275 Accrued interest 282,612 189,527 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 2,817,102 $ 923,061

SHARES TO BE ISSUED

SHARES TO BE ISSUED	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Shares To Be Issued
SHARES TO BE ISSUED	NOTE 9 – SHARES TO BE ISSUED As of March 31, 2023 and December 31, 2022, the balances of shares to be issued were 975,174 and $ 975,174 , respectively. The balance as of March 31, 2023 is comprised of the following: ● As of December 31, 2022, the Company had not yet issued 5,204,352 shares of common stock with a value of $ 247,707 for past services provided and for an acquisition in previous years. ● During the year ended December 31, 2022, pursuant to the acquisition of Stage It described throughout this Report, an additional 72,026,422 shares remain issuable to Stage It shareholders valued at $ 727,647 .	NOTE 10 – SHARES TO BE ISSUED As of December 31, 2022 and December 31, 2021 the balances of shares to be issued were 975,174 247,707 ● As of December 31, 2021 the Company had not yet issued 5,204,352 247,707 ● During the year ended December 31, 2022, pursuant to the acquisition of Stage It described throughout this Report, an additional 72,026,422 727,647

NOTES PAYABLE

NOTES PAYABLE	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Notes Payable
NOTES PAYABLE	NOTE 10 – NOTES PAYABLE The balance of the Notes Payable outstanding as of March 31, 2023, and December 31, 2022, was $ 1,159,262 and $ 1,134,262 , respectively. The balances as of March 31, 2023, were comprised of numerous 8% notes for $ 885,157 due to Ylimit, payable on September 30, 2023, and $ 274,104 in notes due to former Stage It shareholders.	NOTE 11 – NOTES PAYABLE The balance of the Notes Payable outstanding as of December 31, 2022, and December 31, 2021, was $ 1,134,262 869,157 12,000 8 857,157 During 2022 one of the two notes comprising the $ 12,000 3,000 10 During the year ended December 31, 2022, the Company added $ 274,105

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 11 – CONVERTIBLE NOTES PAYABLE Convertible notes payable consist of the following: Schedule of convertible notes payable March 31, December 31, Various Convertible Notes (a) $ 131,703 131,703 Golock Capital, LLC Convertible Notes (b) 339,011 339,011 Total Convertible Notes $ 470,714 470,714 (a) This total is comprised of six convertible notes with five different noteholders. With the exception of one note for $28,500 due to a former related party which is interest free, all of the remaining notes at a 10% interest rate are past due their maturity. The Company has not received any default notices on these notes and continues to accrue interest on these notes. Additionally, $73,204 of these notes due to DBW Investments is in dispute. (b) On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $ 40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018 . The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $ 0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $ 0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totalling $ 40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $ 553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $ 43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $ 302,067 and $ 0 , respectively, as of December 31, 2018. On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months, exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that Golock requested conversion. During the year ending December 31, 2019, the Company issued new notes payable of $ 53,331 , and $ 23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019 was $ 339,010 . As of December 31, 2019, $ 285,679 of these notes were past due. As of March 31, 2023, all of the Golock notes amounting to $ 339,011 were past due. As a result, Golock has assessed the Company additional penalties and interest of $ 1,172,782 . The Company disagrees with the accrued interest and penalties due to Golock. Initially, the Company recorded this amount as a liability on its balance during the period ended 2021. Subsequently, during the three-month period ended September 30, 2021, the Company obtained a legal opinion supporting its position that these charges were egregious and reversed the liability on its balance sheet. The Company intends to litigate this amount as well as the validity of the principal and interest outstanding if a settlement on a vastly reduced amount cannot be reached.	NOTE 12 – CONVERTIBLE NOTES PAYABLE Convertible notes payable consist of the following: Schedule of Convertible notes payable December 31, December 31, Various Convertible Notes $ 43,500 43,500 Golock Capital, LLC Convertible Notes (a) 339,011 339,011 Other Convertible Notes (b) 88,203 253,203 Total Convertible Notes $ 470,714 635,714 (a) On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Lender”) in the principal amount of $ 40,000 10 November 2, 2018 0.015 2,500,000 0.015 40,000 553,000 43,250 302,067 0 On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that the Lender requested conversion. During the year ending December 31, 2019, the Company issued new notes payable of $ 53,331 23,102 100,000,000 339,010 285,679 339,011 As a result Golock has assessed the Company additional penalties and interest of $ 1,172,782 (b) During the year ended December 31, 2021, GHS Investments funded an 8 165,000 73,204

STOCKHOLDERS_ DEFICIT

STOCKHOLDERS’ DEFICIT	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 12 – STOCKHOLDERS’ DEFICIT Common stock The Company has authorized 4,000,000,000 shares of $ 0.0001 par value common stock. As of March 31, 2023, and December 31, 2022, there were 1,783,508,869 and 1,676,014,753 shares of common stock issued and outstanding, respectively. During the three months ended March 31, 2023, the Company sold 107,494,116 common shares pursuant to the terms of its equity line and raised $ 258,597 in proceeds. Preferred Stock Series A On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 shares of Common Stock and 20,000,000 shares of Preferred Stock, of which 5,000,000 were designated as Series A Convertible Preferred Stock. As of March 31, 2023 and 2022 the Company had 20,000,000 shares of $ 0.0001 par value preferred stock authorized and there were 4,250,579 shares of Series A Preferred Stock issued and outstanding. On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 restricted shares of Series A Preferred Stock to various employees and service providers to compensate and reward them for services and to incentivize them to provide continued service to the Company. The Series A Preferred Stock receives relative rights and preferences under terms and conditions set forth in the Certificate of Designation of the Preferred Stock. Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 shares of common stock of the Company. The Series A Preferred Stockholders shall be entitled to share among dividends with the common stock shareholders of the Company on an as-converted basis. The Series A Preferred Stockholders shall vote with the common stock as a single class, on a 100 to 1 basis, such that for every share of Series A Preferred Stock held, such shares shall entitle the holder to cast 100 votes. The holders of the Series A Preferred Stock have no liquidation or redemption preference rights but get treated as common stockholders on an as converted basis. The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company. As of March 31, 2023, and December 31, 2022, there were 4,250,579 shares of Series A Preferred issued and outstanding. Preferred Stock Series B (Update) On January 3, 2022, the Company authorized and designated a class of 2,500 shares, par value $ 0.0001 , of Series B Convertible Preferred Stock (“Series B Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series 5 Designation”). During the three months ended March 31, 2023, the Company issued 117 Preferred B shares to GHS. These share shares were valued as follows: ● 6 shares were considered financing fees valued at $ 6,000 ● 111 shares were used to raise 111,000 in cash As of March 31, 2023, there were 2,422 Warrants In connection with the issuance of Series B Preferred Stock to the Company described in Note 14, the Company issued 279,655,690 warrants, with a five-year life, at an average strike price of $ 0.0788 . A summary of warrants is as follows: Schedule of warrants Number of Weighted Balance outstanding, December 31, 2020 23,805,027 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.00475 Warrants exercised or forfeited (15,800,319 ) Warrants granted during the year ended December 31, 2022 279,655,690 $ 0.00788 (a) Balance outstanding and exercisable, December 31, 2022 279,655,690 Warrants exercised or forfeited - Warrants granted during the three months ended March 31, 2023 55,785,127 Balance outstanding and exercisable, March 31, 2023 335,440,817 (a) The strike price is subject to adjustment based on the market price of the Company’s stock price. Information relating to outstanding warrants on March 31, 2023, summarized by exercise price, is as follows: The weighted-average remaining contractual life of all warrants outstanding and exercisable on March 31, 2023 is approximately 4.26 years. As of March 31, 2023, there were 58,013,989 warrants “in the money” at an average price of $ 0.00279 with an intrinsic value of approximately $ 93,000 . Preferred Stock Series C On May 25, 2022, the Company authorized and designated a class of 10,000 shares of Series C Preferred Stock, par value $ 0.0001 . The holders of the Series C Preferred Stock shall have the right to cast one million (1,000,000) votes for each share held of record on all matters submitted to a vote of holders of the Company’s common stock. On the same date, the Company issued to each of Zach Bair, Chief Executive Officer & Chairman, Anthony Cardenas, Chief Financial Officer and Director, and Lou Mann, Executive Vice President and Director, 1,000 shares of this newly created Series C Preferred Stock for services rendered. These share which represented 3,000,000,000 (billion) votes, was valued at the trading price of the Company’s securities of $0.0051 on the date of Board of Director approval. As a result, the Company recorded a non-cash charge of $ 15,300,000 on its Statement of Operation for the three months ended June 30, 2022. As of March 31, 2023 and December 31, 2022, there were 3,000 shares of Series C Preferred Stock outstanding.	NOTE 13 – STOCKHOLDERS’ DEFICIT Common stock The Company has authorized 2,000,000,000 shares of $ 0.0001 1,676,014,753 1,411,799,497 Preferred Stock Series A On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 20,000,000 5,000,000 As of December 31, 2022 and 2021 the Company had 20,000,000 0.0001 4,250,579 On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 shares of common stock of the Company. The Series A Preferred Stockholders shall be entitled to share among dividends with the common stock shareholders of the Company on an as-converted basis. The Series A Preferred Stockholders shall vote with the common stock as a single class, on a 100 to 1 basis, such that for every share of Series A Preferred Stock held, such shares shall entitle the holder to cast 100 votes. The holders of the Series A Preferred Stock have no liquidation or redemption preference rights but get treated as common stockholders on an as converted basis. The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company. As of December 31, 2022, and December 31, 2021, there were 4,250,579 Preferred Stock Series B (Update) On January 3, 2022, the Company authorized and designated a class of 1,600 0.0001 During the year ended December 31, 2022 the Company issued 2,305 ● 1,980 1,964,600 ● 266 319,200 ● 59 68,400 Warrants In connection with the issuance of Series B Preferred Stock to the Company described in Note 14, the Company issued 279,655,690 0.0788 A summary of warrants is as follows: Schedule of warrants Number of Weighted Balance outstanding, December 31, 2020 23,805,027 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.00475 Warrants exercised or forfeited (15,800,319 ) Warrants granted during the year ended December 31, 202 279,655,690 $ 0.00788 (a) Balance outstanding and exercisable, December 31, 2022 279,655,690 (a) The strike price is subject to adjustment based on the market price of the Company’s stock price Information relating to outstanding warrants on December 31, 2022, summarized by exercise price, is as follows: The weighted-average remaining contractual life of all warrants outstanding and exercisable on December 31, 2022 is approximately 4.51 70,013,989 0.002845 39,000 Preferred Stock Series C On May 25, 2022 the Company authorized and designated a class of 10,000 0.0001 1,000,000 1,000 3,000,000,000 0.0051 15,300,000

COMMITMENT AND CONTINGENCIES

COMMITMENT AND CONTINGENCIES	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENT AND CONTINGENCIES	NOTE 13 – COMMITMENT AND CONTINGENCIES Litigation Legal Matters In the matter of VNUE, Inc. v. Power Up Lending Group, Ltd. On October 6, 2021, the Company commenced an action against Power Up Lending Group, Ltd. (“Power Up”) and Curt Kramer (“Kramer”) (Power Up and Kramer together, the “Power Up Parties”) in the United States District Court for the Eastern District of New York. The complaint alleges that: (1) Power Up is an unregistered dealer acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”) and, pursuant to Section 29(b) of the Act, the Company is entitled to recessionary relief from certain convertible promissory notes (“Notes”) and securities purchase agreements (“SPAs”) entered into by the Company and Power Up; (2) Kramer is liable to the Company as the control person of Power Up pursuant to Section 20(a) of the Act; and (3) Power Up is liable to the Company for unjust enrichment arising from the Notes and SPAs. On December 10, 2021, the Power Up Parties filed their pre-motion conference request letter with the Court regarding their forthcoming motion to dismiss the Company’s complaint. On December 17, 2021, the Company filed its opposition thereto. On January 26, 2022, the Company filed its amended complaint, which asserted the same causes of action set forth in the initial complaint, and further alleged that Power Up made material misstatements in connection with the purchase and sale of the Company’s securities in violation of Section 10(b) of the Act and, thus, the Company is entitled to recessionary relief from the Notes and SPAs pursuant to Section 29(b) of the Act. On February 9, 2022, the Court ordered an initial conference. The initial conference is currently scheduled for May 16, 2022, at 12:00 p.m. (EST). As of the date hereof, the Company intends to litigate its claims for relief against the Power Up Parties. On June 7, 2022, the Company filed a voluntary dismissal of the action because the parties reached a confidential settlement. Golock Capital, LLC and DBW Investments, LLC v. VNUE, Inc. On September 29, 2021, Golock Capital, LLC (“Golock”) and DBW Investments, LLC (“DBW”) (Golock and DBW together, the “Golock Plaintiffs”) commenced an action against the Company in the United States District Court for the Southern District of New York. The Golock Plaintiffs’ complaint alleges that the Company is in breach of certain convertible promissory notes and securities purchase agreements separately entered into with Golock and DBW and seeks declaratory judgment, injunctive relief, and specific performance against the Company. On December 2, 2021, the Golock Plaintiffs filed their amended complaint, which asserted the same causes of action set forth in the initial complaint and an additional cause of action for unjust enrichment. On January 19, 2022, the Company filed its answer with affirmative defenses to the amended complaint. As to its affirmative defenses, the Company asserted that the Golock Plaintiff’s claims are barred because: (1) the Golock Plaintiffs are unregistered dealers acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”), and, pursuant to Section 29(b) of the Act, that the Company is entitled to recessionary relief from the certain convertible promissory notes and securities purchase agreements at issue in the amended complaint; and (2) that the convertible promissory notes are, in fact, criminally usurious loans that impose interest onto the Company at a rate that violates New York Penal Law § 190.40 and, therefore, the subject convertible notes are void ab initio pursuant to New York’s usury laws. On January 20, 2022, the Court ordered that the parties submit a joint letter in lieu of a pretrial conference on or before February 3, 2022. As of the date hereof, the Company intends to vigorously defend itself against the Golock Plaintiff’s claims. On September 1, 2022, the Company filed an amended answer with counterclaims against the Golock Plaintiffs and their control persons asserting claims under the Racketeer Influenced and Corrupt Organizations Act (“RICO”) and the Act. On September 23, the Golock Plaintiffs filed a motion to dismiss the counterclaims. On February 14, 2023, the Court granted the motion to dismiss and also dismissed all claims against the Golock Plaintiff’s control persons. The Company remains committed to actively litigating its affirmative defenses under the Act of and RICO.	NOTE 14 – COMMITMENT AND CONTINGENCIES Litigation Legal Matters In the matter of VNUE, Inc. v. Power Up Lending Group, Ltd. On October 6, 2021, the Company commenced an action against Power Up Lending Group, Ltd. “Power Up”) and Curt Kramer (“Kramer”) (Power Up and Kramer together, the “Power Up Parties”) in the United States District Court for the Eastern District of New York. The complaint alleges that: (1) Power Up is an unregistered dealer acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”) and, pursuant to Section 29(b) of the Act, the Company is entitled to recessionary relief from certain convertible promissory notes (“Notes”) and securities purchase agreements (“SPAs”) entered into by the Company and Power Up; (2) Kramer is liable to the Company as the control person of Power Up pursuant to Section 20(a) of the Act; and (3) Power Up is liable to the Company for unjust enrichment arising from the Notes and SPAs. On December 10, 2021, the Power Up Parties filed their pre-motion conference request letter with the Court regarding their forthcoming motion to dismiss the Company’s complaint. On December 17, 2021, the Company filed its opposition thereto. On January 26, 2022, the Company filed its amended complaint, which asserted the same causes of action set forth in the initial complaint, and further alleged that Power Up made material misstatements in connection with the purchase and sale of the Company’s securities in violation of Section 10(b) of the Act and, thus, the Company is entitled to recessionary relief from the Notes and SPAs pursuant to Section 29(b) of the Act. On February 9, 2022, the Court ordered an initial conference. The initial conference is currently scheduled for May 16, 2022, at 12:00 p.m. (EST). As of the date hereof, the Company intends to litigate its claims for relief against the Power Up Parties. On June 7, 2022, the Company filed a voluntary dismissal of the action because the parties’ reached a confidential settlement. Golock Capital, LLC and DBW Investments, LLC v. VNUE, Inc. On September 29, 2021, Golock Capital, LLC (“Golock”) and DBW Investments, LLC (“DBW”) (Golock and DBW together, the “Golock Plaintiffs”) commenced an action against the Company in the United States District Court for the Southern District of New York. The Golock Plaintiffs’ complaint alleges that the Company is in breach of certain convertible promissory notes and securities purchase agreements separately entered into with Golock and DBW and seeks declaratory judgment, injunctive relief, and specific performance against the Company. On December 2, 2021, the Golock Plaintiffs filed their amended complaint, which asserted the same causes of action set forth in the initial complaint, and an additional cause of action for unjust enrichment. On January 19, 2022, the Company filed its answer with affirmative defenses to the amended complaint. As to its affirmative defenses, the Company asserted that the Golock Plaintiffs claims are barred because: (1) the Golock Plaintiffs are unregistered dealers acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”), and, pursuant to Section 29(b) of the Act, that the Company is entitled to recessionary relief from the certain convertible promissory notes and securities purchase agreements at issue in the amended complaint; and (2) that the convertible promissory notes are, in fact, criminally usurious loans that impose interest onto the Company at a rate that violates New York Penal Law § 190.40 and, therefore, the subject convertible notes are void ab initio pursuant to New York’s usury laws. On January 20, 2022, the Court ordered that the parties submit a joint letter in lieu of a pretrial conference on or before February 3, 2022. As of the date hereof, the Company intends to vigorously defend itself against the Golock Plaintiffs claims. On September 1, 2022, the Company filed an amended answer with counterclaims against the Plaintiffs and their control persons asserting claims under the Racketeer Influenced and Corrupt Organizations Act (“RICO”) and the Act. On September 23, the Plaintiffs filed a motion to dismiss the counterclaims. On February 14, 2023, the Court granted the motion to dismiss and also dismissed all claims against the Plaintiffs’ control persons. The Company remains committed to actively litigating its affirmative defenses under the Act of and RICO.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14 – SUBSEQUENT EVENTS Subsequent to March 31, 2023, the Company sold 70,757,457 198,000	NOTE 15 – SUBSEQUENT EVENTS Subsequent to December 31, 2023 the Company issued a total of 139,844,769 355,000 117 111,000

PURCHASE LIABILITY

PURCHASE LIABILITY	12 Months Ended
	Dec. 31, 2022
Purchase Liability
PURCHASE LIABILITY	NOTE 9 – PURCHASE LIABILITY The balance of the company’s Purchase Liability at December 31, 2022, and December 31, 2021 was $- 0 300,000 Under the terms of the business acquisition of Stage It described in Note 6, during the year ended December 31, 2022 the Company had a contingent Earnout Liability of $ 7,679,984 On October 16, 2017, the Company entered into an agreement with PledgeMusic, Inc. (the “Seller”), whereby the Company acquired the digital live music distribution platform “Set.fm” from PledgeMusic. The purchase price for the acquisition was comprised of $ 50,000 300,000 The purchase liability was payable on the net revenues derived from VNUE’s live recording and content business and must be paid in full to the Seller no later than the three (3) year anniversary of the date of the agreement, or October 16, 2020. If the Company fails to pay the Seller the purchase liability on time, the Seller may request at any time within one hundred eighty days (180) days following the (3) year anniversary of the asset purchase agreement, that the Company immediately forfeit, convey, assign, and transfer to the Seller all or any of the Purchased Assets so requested by the Seller for no additional consideration. The Company has had no correspondence regarding this liability with Pledge Music, who declared bankruptcy in 2019.

SIGNIFICANT AND CRITICAL ACCO_2

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Consolidation	Basis of Consolidation The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp.	Basis of Consolidation The accompanying financial statements have been prepared in accordance with the Financial Accounting Standards Board (“ FASB Codification GAAP The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed, the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer; however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. The Company also recognizes revenue from the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed, which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. As of March 31, 2023 and December 31, 2022, deferred revenue amounted to $ 872,990 and $ 862,597 , respectively. As of March 31, 2023, deferred revenue was comprised of two amounts, $74,225 at VNUE related to the Matchbox Twenty Tour with Rob Thomas that was cancelled due to Covid-19, and $ 798,765 in unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive approximately 80%, and the Company will record 20% of the value of these notes as revenue.	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer, however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production. The Company also recognizes revenue on the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased. As of December 31, 2022 and December 31, 2021 deferred revenue amounted to $ 862,597 74,225 , respectively. As of December 31, 2022, deferred revenue was comprised of two amounts, $74,225 at VNUE related to the Matchbox Twenty Tour with Rob Thomas that was cancelled due to Covid-19, and $ 788,372 in unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes will be redeemed, on average the performing artists will receive 80%, and the Company will record 20% of the value of these notes as revenue.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the assumptions used for the determination of goodwill and intangible assets, the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.
Stock Purchase Warrants	Stock Purchase Warrants The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity.	Stock Purchase Warrants The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments, such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.	Fair Value of Financial Instruments The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. There were no derivative liabilities outstanding as of March 31, 2023 and December 31, 2022.	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. There were no derivative liabilities outstanding as of December 31, 2022 and December 31, 2021.
Income (Loss) per Common Share	Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on March 31, 2023, because their impact would have been anti-dilutive.	Income (Loss) per Common Share Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on December 31, 2022, because their impact would have been anti-dilutive.
Property and Equipment	Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows: Schedule of property plant equipment estimated useful lives Computers, software, and office equipment 3 years Furniture and fixtures 7 years As of March 31, 2023, the Company’s property, which consisted solely of computers at its Stage It subsidiary, was fully depreciated. Depreciation expense for the three months ended March 31, 2023, and 2022, amounted to $ 9,134 and $ 1,880 , respectively.	Property and Equipment Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows: Schedule of Property Plant Equipment Estimated Useful Lives Computers, software, and office equipment 3 years Furniture and fixtures 7 years As of December 31, 2022 and 2021, the Company’s property, which consisted solely of computers at its Stage It subsidiary, amounted to $ 9,134 , net of accumulated depreciation and -$- 0 - respectively. Depreciation expense for the year ended December 31, 2022, and 2021, amounted to $ 28,688 and $- 0 - respectively.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years. Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. As of December 31, 2022, the Company determined that its goodwill and intangibles were fully impaired, and as a result, recorded an impairment of goodwill and intangible assets amounting to $ 4,261,683 in its Statements Operations for the year ended December 31, 2022.	Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years. Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. As of December 31, 2022 the Company determined that its goodwill and intangibles were fully impaired, and as a result recorded an impairment of goodwill and intangible assets amounting to $ 4,261,683 in its Statements Operations for the year ended December 31, 2022.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material effect on the Company’s financial statements and financial statement disclosures.	Recently Issued Accounting Pronouncements In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material effect on the Company’s financial statements and financial statement disclosures.

SIGNIFICANT AND CRITICAL ACCO_3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of Property Plant Equipment Estimated Useful Lives	Schedule of property plant equipment estimated useful lives Computers, software, and office equipment 3 years Furniture and fixtures 7 years	Schedule of Property Plant Equipment Estimated Useful Lives Computers, software, and office equipment 3 years Furniture and fixtures 7 years

PREPAID EXPENSE (Tables)

PREPAID EXPENSE (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule Of Prepaid Expense	Schedule of prepaid expense March 31, December 31, Matchbox Twenty agreement $ 100,000 $ 100,000 Deposit with joint venture partner 161,100 30,000 Total prepaid expenses $ 261,100 $ 130,000	Schedule Of Prepaid Expense December 31, December 31, Matchbox Twenty agreement $ 100,000 $ 100,000 Deposit with joint venture partner 30,000 - Pre-acquisition expenses paid at Stage It - 364,336 Total prepaid expenses $ 130,000 $ 464,336

BUSINESS ACQUISITION (Tables)

BUSINESS ACQUISITION (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of fair value of consideration	Schedule of fair value of consideration Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share $ 418,917 Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share 944,583 Net liabilities assumed 2,871,066 Cash paid 1,085,450 Fair value of total consideration paid $ 5,320,016	Schedule of fair value of consideration Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share $ 418,917 Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share 944,583 Net liabilities assumed 2,871,066 Cash paid 1,085,450 Fair value of total consideration paid $ 5,320,016
Schedule of net asset acquired and liabilities assumed	Schedule of net asset acquired and liabilities assumed Cash and cash equivalents $ 107,689 Computer equipment 36,882 Total assets 144,571 Accounts payable and accrued liabilities 1,711,349 Notes payable 526,385 Deferred revenue 777,903 Total liabilities $ 3,015,637 Net liabilities assumed $ 2,871,066	Schedule of net asset acquired and liabilities assumed Cash and cash equivalents $ 107,689 Computer equipment 36,882 Total assets 144,571 Accounts payable and accrued liabilities 1,711,349 Notes payable 526,385 Deferred revenue 777,903 Total liabilities $ 3,015,637 Net liabilities assumed $ 2,871,066
Schedule of Net impairment	Schedule of net impairment Goodwill impairment $ 10,400,000 Intangible assets impairment 1,542,847 Reversal of Earnout liability (7,679,984 ) Net impairment $ 4,262,863	Schedule of Net impairment Goodwill impairment $ 10,400,000 Intangible assets impairment 1,542,847 Reversal of Earnout liability (7,679,984 ) Net impairment $ 4,262,863

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Schedule of accrued liabilities	Schedule of accrued liabilities March 31, 2023 December 31, 2022 Accounts payable and accrued expense $ 2,435,129 $ 2,389,231 Accrued interest 306,178 282,612 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 2,886,566 $ 2,817,102	Schedule of accrued liabilities December 31, 2022 December 31, 2021 Accounts payable and accrued expense $ 2,389,231 $ 588,275 Accrued interest 282,612 189,527 Soundstr Obligation 145,259 145,259 Total accounts payable and accrued liabilities $ 2,817,102 $ 923,061

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of Convertible notes payable	Schedule of convertible notes payable March 31, December 31, Various Convertible Notes (a) $ 131,703 131,703 Golock Capital, LLC Convertible Notes (b) 339,011 339,011 Total Convertible Notes $ 470,714 470,714 (a) This total is comprised of six convertible notes with five different noteholders. With the exception of one note for $28,500 due to a former related party which is interest free, all of the remaining notes at a 10% interest rate are past due their maturity. The Company has not received any default notices on these notes and continues to accrue interest on these notes. Additionally, $73,204 of these notes due to DBW Investments is in dispute. (b) On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $ 40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018 . The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $ 0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $ 0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totalling $ 40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $ 553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $ 43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $ 302,067 and $ 0 , respectively, as of December 31, 2018. On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months, exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that Golock requested conversion. During the year ending December 31, 2019, the Company issued new notes payable of $ 53,331 , and $ 23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019 was $ 339,010 . As of December 31, 2019, $ 285,679 of these notes were past due. As of March 31, 2023, all of the Golock notes amounting to $ 339,011 were past due. As a result, Golock has assessed the Company additional penalties and interest of $ 1,172,782 . The Company disagrees with the accrued interest and penalties due to Golock. Initially, the Company recorded this amount as a liability on its balance during the period ended 2021. Subsequently, during the three-month period ended September 30, 2021, the Company obtained a legal opinion supporting its position that these charges were egregious and reversed the liability on its balance sheet. The Company intends to litigate this amount as well as the validity of the principal and interest outstanding if a settlement on a vastly reduced amount cannot be reached.	Schedule of Convertible notes payable December 31, December 31, Various Convertible Notes $ 43,500 43,500 Golock Capital, LLC Convertible Notes (a) 339,011 339,011 Other Convertible Notes (b) 88,203 253,203 Total Convertible Notes $ 470,714 635,714

STOCKHOLDERS_ DEFICIT (Tables)

STOCKHOLDERS’ DEFICIT (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Equity [Abstract]
Schedule of warrants	Schedule of warrants Number of Weighted Balance outstanding, December 31, 2020 23,805,027 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.00475 Warrants exercised or forfeited (15,800,319 ) Warrants granted during the year ended December 31, 2022 279,655,690 $ 0.00788 (a) Balance outstanding and exercisable, December 31, 2022 279,655,690 Warrants exercised or forfeited - Warrants granted during the three months ended March 31, 2023 55,785,127 Balance outstanding and exercisable, March 31, 2023 335,440,817 (a) The strike price is subject to adjustment based on the market price of the Company’s stock price.	Schedule of warrants Number of Weighted Balance outstanding, December 31, 2020 23,805,027 Warrants expired or forfeited (8,004,708 ) - Balance outstanding and exercisable, December 31, 2021 15,800,319 $ 0.00475 Warrants exercised or forfeited (15,800,319 ) Warrants granted during the year ended December 31, 202 279,655,690 $ 0.00788 (a) Balance outstanding and exercisable, December 31, 2022 279,655,690 (a) The strike price is subject to adjustment based on the market price of the Company’s stock price

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Feb. 14, 2022	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Cash paid	$ 1,085,450	$ 1,085,450
Common Stock, Shares Subscribed but Unissued		5,204,352	135,000,000	5,204,352
TGRI [Member]
Restructuring Cost and Reserve [Line Items]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	50,762,987	50,762,987

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 54,191		$ 82,807	$ 36,958
Negative working capital	6,524,049		(6,469,779)
Accumulated deficit	37,247,403		36,808,403	13,835,294
Net cash used in operating activities	412,213	$ 248,739	1,276,439	$ 1,430,312
Negative working capital	$ (6,524,049)		$ 6,469,779

SIGNIFICANT AND CRITICAL ACCO_4

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
[custom:PropertyPlantAndEquipmentUsefulLifes]	3 years	7 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
[custom:PropertyPlantAndEquipmentUsefulLifes]	7 years	3 years

SIGNIFICANT AND CRITICAL ACCO_5

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Deferred Revenue	$ 872,990		$ 862,597	$ 74,225
Depreciation	9,134	$ 1,880	28,688	0
Goodwill and Intangible Asset Impairment	4,261,683		4,261,683
Property, Plant and Equipment, Net			9,134	$ 0
Rob Thomas [Member]
Defined Benefit Plan Disclosure [Line Items]
[custom:UnredeemedAmount-0]	$ 798,765		$ 788,372

PREPAID EXPENSE (Details)

PREPAID EXPENSE (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Matchbox Twenty agreement	$ 100,000	$ 100,000	$ 100,000
Deposit with joint venture partner	161,100	30,000
Total prepaid expenses	$ 261,100	130,000	464,336
Pre-acquisition expenses paid at Stage It			$ 364,336

PREPAID EXPENSE (Details Narrat

PREPAID EXPENSE (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Jan. 09, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Prepaid Expense, Current	$ 261,100	$ 130,000	$ 464,336	$ 100,000
MT Agreement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Description of payment	Company agreed to pay an advance of $100,000 against sales to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.	Company agreed to pay an advance of $100,000 against sales, to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
[custom:RevenuesFromRelatedParty]	$ 3,875	$ 5,049	$ 11,818	$ 100,476
License cost	$ 194	$ 252	591	5,024
Chief Executive Officers [Member]
Related Party Transaction [Line Items]
[custom:AdvancesFromCompany-0]			$ 10,000	$ 10,000

BUSINESS ACQUISITION (Details)

BUSINESS ACQUISITION (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Feb. 13, 2022
Business Acquisition [Line Items]
Cash paid	$ 1,085,450	$ 1,085,450
V N U E Acquisition [Member]
Business Acquisition [Line Items]
Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share			$ 418,917
Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share			944,583
Net liabilities assumed			2,871,066
Cash paid			1,085,450
Fair value of total consideration paid			$ 5,320,016

BUSINESS ACQUISITION (Details 1

BUSINESS ACQUISITION (Details 1) - V N U E Acquisition [Member]	Feb. 13, 2022 USD ($)
Business Acquisition [Line Items]
Cash and cash equivalents	$ 107,689
Computer equipment	36,882
Total assets	144,571
Accounts payable and accrued liabilities	1,711,349
Notes payable	526,385
Deferred revenue	777,903
Total liabilities	3,015,637
Net liabilities assumed	$ 2,871,066

BUSINESS ACQUISITION (Details 2

BUSINESS ACQUISITION (Details 2)	12 Months Ended
	Dec. 31, 2022 USD ($)
Business Combination and Asset Acquisition [Abstract]
Goodwill impairment	$ 10,400,000
Intangible assets impairment	1,542,847
Reversal of Earnout liability	(7,679,984)
Net impairment	$ 4,262,863

BUSINESS ACQUISITION (Details N

BUSINESS ACQUISITION (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Feb. 14, 2022	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Feb. 13, 2022
Business Acquisition [Line Items]
Amortization				$ 758,333
[custom:ImpairmentOfGoodwillAndIntangibleAssetsCharge]				4,262,683
Amortization of Intangible Assets			$ 108,333	$ 758,333
V N U E Acquisition [Member]
Business Acquisition [Line Items]
Stock Issued During Period, Shares, Acquisitions	135,000,000
Fair value consideration paid to goodwill						$ 10,400,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets						$ 2,600,000

DEFERRED REVENUE (Details Narra

DEFERRED REVENUE (Details Narrative) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Deferred Revenue	$ 872,990	$ 862,597	$ 74,225
Rob Thomas [Member]
Defined Benefit Plan Disclosure [Line Items]
[custom:UnredeemedNotes-0]	$ 798,765	$ 788,372

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Accounts payable and accrued expense	$ 2,435,129	$ 2,389,231	$ 588,275
Accrued interest	306,178	282,612	189,527
Soundstr Obligation	145,259	145,259	145,259
Total accounts payable and accrued liabilities	$ 2,886,566	$ 2,817,102	$ 923,061

SHARES TO BE ISSUED (Details Na

SHARES TO BE ISSUED (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 31, 2023	Feb. 14, 2022	Dec. 31, 2021
Shares To Be Issued
Common stock to be issued, value	$ 975,174	$ 975,174		$ 247,707
Common stock to be issued, shares	5,204,352		135,000,000	5,204,352
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable	$ 247,707
Number of shares issuable	72,026,422
Number of shares issuable, value	$ 727,647

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Notes Payable	$ 1,159,262	$ 1,134,262	$ 869,157
Accruing interest	8%	10%	8%
Other Notes Payable		$ 885,157	$ 857,157
Liabilities for acquisition	$ 274,104	274,105
Paid off leaving		$ 3,000
Note Payable [Member]
Short-Term Debt [Line Items]
Notes Payable			$ 12,000

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)		1 Months Ended	3 Months Ended
		Feb. 02, 2018	Mar. 31, 2023		Dec. 31, 2022		Dec. 31, 2021		Dec. 31, 2018
Short-Term Debt [Line Items]
Convertible notes payable			$ 470,714		$ 470,714		$ 635,714
Sale of Stock, Number of Shares Issued in Transaction			107,494,116
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.00475
Various Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable	[1]		$ 131,703		131,703
Golock Capital, LLC Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable			$ 339,011	[2]	339,011	[2],[3]	$ 339,011	[3]
Debt Instrument, Face Amount		$ 40,000
Debt Instrument, Interest Rate, Stated Percentage		10%
Debt Instrument, Convertible, Conversion Price		$ 0.015
Sale of Stock, Number of Shares Issued in Transaction		2,500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.015
Related debt discount		$ 40,000							$ 0
Increase (Decrease) in Derivative Liabilities		553,000
Debt Issuance Costs, Net		$ 43,250
Convertible Notes Payable, Noncurrent									$ 302,067
Variou Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable					43,500		43,500
Other Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable	[4]				$ 88,203		$ 253,203
[1]This total is comprised of six convertible notes with five different noteholders. With the exception of one note for $28,500 due to a former related party which is interest free, all of the remaining notes at a 10% interest rate are past due their maturity. The Company has not received any default notices on these notes and continues to accrue interest on these notes. Additionally, $73,204 of these notes due to DBW Investments is in dispute.[2]On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $ 40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018 . The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $ 0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $ 0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totalling $ 40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $ 553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $ 43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $ 302,067 and $ 0 , respectively, as of December 31, 2018. 40,000 10 November 2, 2018 0.015 2,500,000 0.015 40,000 553,000 43,250 302,067 0 8 165,000 73,204

CONVERTIBLE NOTES PAYABLE (De_2

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended	12 Months Ended
	Apr. 29, 2019	Feb. 02, 2018	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2019	Dec. 31, 2018
Short-Term Debt [Line Items]
Warrant issued to common stock			107,494,116
Exercise price					$ 0.00475
G H S Investments [Member]
Short-Term Debt [Line Items]
Interest rate				8%
Convertible promissory note					$ 165,000
Golock Capital, LLC Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable							$ 302,067
Debt instrument, principal amount			$ 339,011	$ 339,011
Amount of additional penalties and interest			$ 1,172,782	1,172,782
Principal amount		$ 40,000
Interest rate		10%
Maturity date description		November 2, 2018
Conversion price		$ 0.015
Warrant issued to common stock		2,500,000
Exercise price		$ 0.015
Related debt discount		$ 40,000					$ 0
Increase/decrease in derivative liability		553,000
Financing cost		$ 43,250
Amendment [Member] | Golock [Member]
Short-Term Debt [Line Items]
Debt Instrument, Description	They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months, exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that Golock requested conversion.
Debt conversion, converted instrument, amount						$ 53,331
Debt conversion, converted instrument, accured interest						$ 23,102
Debt conversion, converted instrument, shares issued						100,000,000
Convertible notes payable						$ 339,010
Notes past due						$ 285,679
Amendment [Member] | Lender [Member]
Short-Term Debt [Line Items]
Notes past due				$ 73,204

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details) - $ / shares		3 Months Ended	12 Months Ended
		Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Number of warrants, Begining Balance		279,655,690	15,800,319	23,805,027
Number of warrants, Warrants expired or forfeited			(15,800,319)	(8,004,708)
Weighted average exercise price, Warrants expired or forfeited
Weighted average exercise price, Warrants outstanding				$ 0.00475
Warrants granted		55,785,127	279,655,690
Weighted Average Exercise Price, Warrants granted	[1],[2]		$ 0.00788
Number of warrants, Ending Balance		335,440,817	279,655,690	15,800,319
[1]The strike price is subject to adjustment based on the market price of the Company’s stock price.[2]The strike price is subject to adjustment based on the market price of the Company’s stock price

STOCKHOLDERS_ DEFICIT (Details

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		12 Months Ended
	May 25, 2022	Jul. 02, 2019	Mar. 31, 2023	Jun. 30, 2022	Dec. 31, 2022	May 22, 2022	Jan. 03, 2022	Dec. 31, 2021	May 22, 2019
Class of Stock [Line Items]
Common Stock, Shares Authorized					4,000,000,000			2,000,000,000
Common stock par value					$ 0.0001			$ 0.0001
Common stock, shares outstanding			1,783,508,869		1,676,014,753			1,411,799,497
Sale of Stock, Number of Shares Issued in Transaction			107,494,116
Sale of Stock, Consideration Received on Transaction			$ 258,597
Common stock capitalized		2,000,000,000
Preferred stock capitalized		5,000,000
Warrants issued			279,655,690		279,655,690
Strike price			$ 0.0788		$ 0.0788
Weighted-average remaining contractual life			4 years 3 months 3 days		4 years 6 months 3 days
Average price			$ 0.00279		$ 0.002845
Intrinsic value			$ 93,000		$ 39,000
Non cash charge				$ 15,300,000
Common stock, shares issued					1,676,014,753			1,411,799,497
Financing fees					59
Financing fee					$ 68,400
Warrants					70,013,989
Trading price					$ 0.0051
Board of Directors Chairman [Member]
Class of Stock [Line Items]
Preferred Stock, Voting Rights	These share which represented 3,000,000,000 (billion) votes, was valued at the trading price of the Company’s securities of $0.0051 on the date of Board of Director approval.
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			20,000,000		20,000,000			20,000,000
Preferred stock, shares par value					$ 0.0001			$ 0.0001
Preferred stock shares outstanding			4,250,579		4,250,579			4,250,579
Preferred stock, shares issued					4,250,579			4,250,579
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized		20,000,000
Designated shares									4,126,776
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			2,500		2,500			2,500
Preferred stock, shares par value			$ 0.0001		$ 0.0001			$ 0.0001
Preferred stock shares outstanding			2,422		2,305			0
Shares issued for proceeds			6		1,980
Proceeds from issuance of preferred stock			$ 6,000		$ 1,964,600
Shares issued issued to retire debt			111		266
Shares issued issued to retire debt, value			$ 111,000		$ 319,200
Series B Preferred Stock [Member] | G H S Investments [Member]
Class of Stock [Line Items]
Shares issued for proceeds			117		2,305
Series B Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares par value							$ 0.0001
Designated shares			2,422				1,600
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized					100,000			100,000
Preferred stock, shares par value					$ 0.0001			$ 0.0001
Preferred stock shares outstanding			3,000		0
Designated shares	10,000
Preferred Stock, No Par Value	$ 0.0001
Preferred Stock, Voting Rights	The holders of the Series C Preferred Stock shall have the right to cast one million (1,000,000) votes for each share held of record on all matters submitted to a vote of holders of the Company’s common stock.
Preferred Stock Series C [Member]
Class of Stock [Line Items]
Shares, Outstanding					3,000
Series C Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized						10,000
Preferred stock, shares par value						$ 0.0001
Common stock voting rights					1,000,000
Number of shares issued					3,000,000,000
Series C Convertible Preferred Stock [Member] | Board of Directors Chairman [Member]
Class of Stock [Line Items]
Number of shares issued					1,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	2 Months Ended	3 Months Ended
	Dec. 31, 2023	May 19, 2023	Mar. 31, 2023
Subsequent Event [Line Items]
Sale of Stock, Number of Shares Issued in Transaction			107,494,116
Forecast [Member]
Subsequent Event [Line Items]
Number of shares issued	139,844,769
Gross proceeds	$ 355,000
Forecast [Member] | G H S [Member]
Subsequent Event [Line Items]
Number of shares issued	117
Gross proceeds	$ 111,000
Subsequent Event [Member] | G H S [Member]
Subsequent Event [Line Items]
Sale of Stock, Number of Shares Issued in Transaction		70,757,457
Proceeds from Lines of Credit		$ 198,000

STOCKHOLDER DEFICIT (Details)

STOCKHOLDER DEFICIT (Details) - $ / shares		3 Months Ended	12 Months Ended
		Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Purchase Liability
Number of warrants, Begining Balance		279,655,690	15,800,319	23,805,027
Number of warrants, Warrants expired or forfeited			(15,800,319)	(8,004,708)
Weighted average exercise price, Warrants expired or forfeited
Weighted average exercise price or warrants outstanding and exercisable, Ending Balance			$ 0.00475
Warrants granted		55,785,127	279,655,690
Weighted Average Exercise Price, Warrants granted	[1],[2]		$ 0.00788
Number of warrants, Ending Balance		335,440,817	279,655,690	15,800,319
[1]The strike price is subject to adjustment based on the market price of the Company’s stock price.[2]The strike price is subject to adjustment based on the market price of the Company’s stock price

PURCHASE LIABILITY (Details Nar

PURCHASE LIABILITY (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Oct. 16, 2017	Dec. 31, 2022	Dec. 31, 2021
Dividends Payable [Line Items]
Earnout Liabilities		$ 7,679,984
Dividend Declared [Member]
Dividends Payable [Line Items]
Purchase liability	$ 300,000	$ 0	$ 300,000
Purchase price	$ 50,000